Novo Nordisk A/s Stock Forecast

Sell candidate since Nov 06, 2025 Gain 3.61%

The Novo Nordisk A/S stock price gained 1.73% on the last trading day (Monday, 17th Nov 2025), rising from $48.17 to $49.00. During the last trading day the stock fluctuated 7.94% from a day low at $46.11 to a day high of $49.77. The price has been going up and down for this period, and there has been a 0.98% gain for the last 2 weeks. Volume fell on the last day by -32 shares and in total, 212 shares were bought and sold for approximately $10.39 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.83% during the next 3 months and, with a 90% probability hold a price between $39.29 and $50.56 at the end of this 3-month period.

NONOF Signals & Forecast

There are mixed signals in the stock today. The Novo Nordisk A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $53.43. On a fall, the stock will find some support from the short-term average at $48.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -1.05%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Novo Nordisk A/S stock

Novo Nordisk A/S finds support from accumulated volume at $48.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $3.66 between high and low, or 7.94%. For the last week the stock has had daily average volatility of 6.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NONOF) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Novo Nordisk A/S to open at $48.29, and during the day (based on 14 day Average True Range), to move between $47.42 and $50.58, which gives a possible trading interval of +/-$3.17 (+/-6.68%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 6.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $48.58 (0.86%) than the resistance at $53.86 (9.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Novo Nordisk A/S stock A Buy?

Novo Nordisk A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.104 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $48.29 ( 1.44%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk